Hostname: page-component-78c5997874-8bhkd Total loading time: 0 Render date: 2024-11-02T19:11:49.899Z Has data issue: false hasContentIssue false
  • English
  • Français

HLA-Matched Donor Registries for Bone Marrow Transplants: A Decision Analysis

Published online by Cambridge University Press:  10 March 2009

Mark H. Eckman ,
Frank A. Sonnenberg ,
Itzhak Jacoby  and
Stephen G. Pauker
Mark H. Eckman
Affiliation:
Tufts University School of Medicine
Frank A. Sonnenberg
Affiliation:
Tufts University School of Medicine
Itzhak Jacoby
Affiliation:
National Institutes of Health, U.S.A.
Stephen G. Pauker
Affiliation:
Tufts University School of Medicine
Get access Rights & Permissions [Opens in a new window]

Extract

Bone marrow transplantation has become an accepted treatment for severe aplastic anemia, acute myelogenous leukemia, and acute lymphocytic leukemia (20;35). Less commonly thalassemia (23), multiple myeloma (25), severe combined immune deficiencies (10), and chronic granulocytic leukemia (14) are also treated with marrow transplantation. Most donors are siblings whose HLA phenotype is identical to the patient's. Such donors, however, are available to only one third of patients (6;16;27;28;35). In the absence of an HLA-identical sibling, partially matched, haplo-identical, related donors (differing by only one major histocom-patibility antigen) can be found for another 7% of patients (1;6;27;37). A variety of lower quality matches also can be found but have not been used extensively. Advances in tissue typing and the treatment of graft versus host disease now allow physicians to consider matched unrelated individuals as potential donors when a suitable related donor is not available (11;12;13;15;17;22).

Type
Special Section: Transplantation and Artificial Organs
Information
International Journal of Technology Assessment in Health Care , Volume 2 , Issue 3 , July 1986 , pp. 507 - 531
Copyright
Copyright © Cambridge University Press 1986

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Beatty, P. G., Thomas, E. D., & Hansen, J. A.The Seattle experience with partially matched related donors and matched unrelated donors. Proceedings of 1985 NIH Consensus Conference on Donor Registries for Bone Marrow Transplantation, 1985, 20–23.Google Scholar
2.Beck, J. R., Pauker, S. G., & Kassirer, J. P.A convenient approximation of life expectancy (the DEALE) I. Validation of the Method. American Journal of Medicine, 1982, 73, 883–88.CrossRefGoogle ScholarPubMed
3.Beck, J. R., Pauker, S. G., Gottlieb, J. E., Klein, K., & Kassirer, J. P.A convenient approximation of life expectancy (the DEALE) II. Use in Medical Decision Making. American Journal of Medicine, 1982, 73, 889–97.CrossRefGoogle ScholarPubMed
4.Biggs, J., Atkinson, K., Concannon, A., Dodds, A., Harkness, J., Yuile, P., Causer, P., Bashir, H., Penny, R., Nicholls, M., Ting, A., Pun, A., & Honeyman, M.Bone marrow transplantation in 33 patients with malignant blood diseases and severe aplastic anemia. The Medical Journal of Australia, 1983, 2, 120–25.CrossRefGoogle Scholar
5.Chan, K., Pollack, M. S., Braun, D. Jr, O'Reilly, R. J., & DuPont, B.Distribution of HLA genotypes in families of patients with acute leukemia. Transplantation, 1982, 33, 613–15.CrossRefGoogle ScholarPubMed
6.Clift, R. A., Hansen, J. A., Beatty, P. G., Mickelson, E. M., Nisperos, B., Martin, P. J., & Thomas, D.Marrow transplantation from donors other than HLA-identical siblings. Transplantation, 1979, 28, 235–42.CrossRefGoogle ScholarPubMed
7.Clift, R. A., Buckner, C. D., Thomas, E. D., Doney, K., Fefer, A., Neiman, P. E., Singer, J., Sanders, J., Stewart, P., Sullivan, K. M., Deeg, J., & Storb, R.Treatment of chronic granulocytic leukemia in chronic phase by Allogeneic marrow transplantation. Lancet, 1982, 2, 621–23.CrossRefGoogle ScholarPubMed
8.Clift, R. A., Beatty, P. G., Thomas, E. D., Buckner, C. D., Weiden, P., & McGuffin, R.Marrow transplantation from mismatched donors for the treatment of malignancy. Transplantation Proceedings, 1985, 17, 445–46.Google Scholar
9.Filipovich, A. H., Ramsay, N. K. C., McGlave, P., Quinones, R., Winslow, C., Heinitx, K. J., Arthur, D., & Kersey, J. H. Mismatched bone marrow transplantation at the University of Minnesota: use of related donors other than HLA MLC identical siblings and T cell depletion. In Gale, R. (ed.), Recent Advances in Bone Marrow Transplantation. New York: Alan R. Liss, Inc., 1983, 769–83.Google Scholar
10.Gale, R.Bone marrow transplantation: current results with HLA-identical and sibling transplants. Proceedings of 1985 NIH Consensus Conference on Donor Registries for Bone Marrow Transplantation, 1985, 17–19.Google Scholar
11.Gingrich, R.Successful bone marrow transplantation with partially matched unrelated donors. Transplantation Proceedings, 1985, 17, 450–52.Google Scholar
12.Gingrich, R., Howe, C. W. S., Goeken, N. E., Ginder, G. D., & Fyfe, M. A.Partial mismatching of the unrelated bone marrow donor in clinical transplantation: A study of feasibility and effectiveness. Proceedings of 1985 NIH Consensus Conference on Donor Registries for Bone Marrow Transplantation, 1985, 43–48.Google Scholar
13.Goeken, N. E., Fyfe, M. A., Howe, C. W. S., Ginder, G. D., & Gingrich, R. D.Establishment and utilization of an unrelated bone marrow donor registry at the University of Iowa. Proceedings of 1985 NIH Consensus Conference on Donor Registries for Bone Marrow Transplantation, 1985, 66–69.Google Scholar
14.Goldman, J. M., Baughan, A. S., McCarthy, D. M., Worsley, A. M., Hows, J. M., Gordon-Smith, S. C., Catovsky, D., Batchelor, J. R., Goolden, A. W., & Galton, D. A.Marrow transplantation for patients in the chronic phase of chronic granulocytic leukaemia. Lancet, 1982, 623–25.CrossRefGoogle ScholarPubMed
15.Gordon-Smith, S. C.Bone-marrow transplantation for severe aplastic anaemia using histocompatible unrelated volunteer donors. British Medical Journal, 1982, 285, 835–37.CrossRefGoogle ScholarPubMed
16.Hansen, J. A. Marrow transplantation from donors other than HLA genotypically identical siblings. In Gale, R. (ed.), Recent Advances in Bone Marrow Transplantation. New York: Alan R. Liss, Inc., 1983, 739–56.Google Scholar
17.Hansen, J. A.Transplantation of marrow from an unrelated donor to a patient with acute leukemia. New England Journal of Medicine, 1980, 303, 565–67.CrossRefGoogle ScholarPubMed
18.Hows, J., Yin, J., Fairhead, S., Chipping, P., Batchelor, R., & Gordeon-Smith, E. C.Unrelated donor transplants for aplastic anemia. Proceedings of 1985 NIH Consensus Conference on Donor Registries for Bone Marrow Transplantation, 1985, 33–38.Google Scholar
19.James, D. C. O. of the Anthony Nolan Registry. Personal communication, May, 1985.Google Scholar
20.Kamani, N. & August, C. S.Bone marrow transplantation: problems and prospects. Medical Clinics of North America, 1984, 68, 657–75.CrossRefGoogle Scholar
21.Kay, H. E. M., Powles, R. L., & Lawler, S. D.Cost of bone-marrow transplantation in acute myeloid leukaemia. Lancet, 1980, 1, 1067–69.CrossRefGoogle ScholarPubMed
22.Liu, Yin J. A.Bone marrow transplants from unrelated donors. Experimental Hematology, 1984, 12, 40–41.Google Scholar
23.Lucarelli, G., Polchi, P., Giardini, C., Angelucci, E., Politi, P., Baronciani, D., Manenti, F., & Delfini, C.Bone marrow transplantation in thalassemia. Proceedings of 1985 NIH Consensus Conference on Donor Registries for Bone Marrow Transplantation, 1985, 24–25.Google ScholarPubMed
24.O'Reilly, R. J., Collins, N. H., Kernan, N., Brochstein, J., Dinsmore, R., Kirkpatrick, D., Siena, S., Keever, C., Jordan, B., Shank, B., Wolfe, L., Dupont, B., & Reisner, Y.Transplantation of marrow-depleted T cells by soybean lectin agglutination and Erosette depletion: Major histocompatibility complex-related graft resistance in leukemic transplant recipients. Transplantation Proceedings, 1985, 17, 455–59.Google Scholar
25.Osserman, E. F., DiRe, L. B., DiRe, J., Sherman, W. H., Hersmamn, J. A., & Storb, R.Identical twin marrow transplantation in multiple myeloma. Acta Haematolologica, 1982, 68, 215–23.CrossRefGoogle ScholarPubMed
26.Powles, R. L., Morgenstern, G. R., Crofts, M., Evans, B., & Lawler, S. D. Mismatched family bone marrow transplantation. In Gale, R. (ed.), Recent Advances in Bone Marrow Transplantation. New York: Alan R. Liss, Inc., 1983, 757–67.Google Scholar
27.Powles, R. L., Morgenstern, G. R., Kay, H. E., McElwain, T. J., Clink, H. M., Dady, P. J., Barrett, A., Jameson, B., Depledge, M. H., Watson, J. G., Sloane, J., Leigh, M., Lumley, H., Hedley, D., Lawler, S. D., Filshie, J., & Robinson, B.Mismatched family donors for bone-marrow transplantation as treatment for acute leukaemia. Lancet, 1985, 1, 612–15.Google Scholar
28.Powles, R. L., Pedrazzini, A., Crofts, M., Clink, H., Miller, J., Bhattia, G., & Perez, D.Mismatched family bone marrow transplantation. Seminars in Hematology, 1984, 21, 182–87.Google ScholarPubMed
29.Ringden, O., Lonnqvist, B., & Lundgren, G.Experience with a cooperative bone marrow transplantation program in Stockholm. Transplantation, 1982, 33, 500–04.CrossRefGoogle ScholarPubMed
30.Rollinson, D. H.The cost of marrow transplantation compared with the cost of conventional treatment for acute leukaemia and aplastic anemia. New Zealand Medical Journal, 1982, 95, 310–11.Google Scholar
31.Schweitzer, S. O., Scalzi, C. C., & Keating, M. V., Social cost versus effectiveness of bone marrow transplant therapy. UCLA Cancer Center Bulletin, 1979, 6, 3–16.Google Scholar
32.Sondel, P. M., Bozdech, M. J., Trigg, M. E., Hong, R., Finlay, J. L., Kohler, P. C., Longo, W., Hank, J. A., Billing, R., Steeves, R., & Flynn, B.Additional immuno-suppression allows engraftment following HLA-mismatched T cell-depleted bone marrow transplantation for leukemia. Transplantation Proceedings, 1985, 17, 460–61.Google Scholar
33.Sonnenberg, F. A., Eckman, M. H., Beck, J. R., Jacobi, I., & Pauker, S. G.Relationship between donor pool size and probability of matching for a volunteer bone marrow donor registry. Clinical Research, 1986, 34, 663A.Google Scholar
34.Spruce, W., McMillan, R., & Beutler, E.Bone marrow transplantation for the treatment of severe aplastic anemia. Clinics in Haematology, 1983, 12, 285–311.CrossRefGoogle Scholar
35.Storb, R. & Santos, G. W.Application of bone marrow transplantation in leukaemia and aplastic anemia. Clinics in Haematology, 1983, 12, 721–37.CrossRefGoogle Scholar
36.Storb, R., Buckner, C. D., Appelbaum, F. R., Clift, R. A., Deeg, H. J., Doney, K., Hansen, J. A., Prentice, R. L., & Sanders, J. E.Marrow transplantation for aplastic anemia. Seminars in Hematology, 1984, 21, 27–35.Google ScholarPubMed
37.Storch, S., Gale, R. P., Champlin, R., Ho, W., Falk, P. M., & Feig, S. A. Partially mismatched marrow transplantation for acute leukemia and aplastic anemia. In Gale, R. (ed.), Recent Advances in Bone Marrow Transplantation. New York: Alan R. Liss, Inc., 1983, 785–95.Google Scholar
38.Van Rood, J. J., Hendriks, G. F., Persijn, G. G., & Gratama, J. W.Lessons to be learned from renal transplantation. Seminars in Hematology, 2, 1984, 159–63.Google Scholar
39.Yunis, E. J., Awdeh, Z., Raum, D., & Alper, C. A.The MHC in human bone marrow allotransplantation. Clinics in Haematology, 1983, 12, 641–81.CrossRefGoogle ScholarPubMed